Health in Romania 1,155 indicators covering health for Romania. IndicatorLatest Year10-yr change Rank Hospital beds 72.32 2022 up 10.2% 8th Treatment success rate for patients treated for MDR-TB 55.0% 2022 up 61.8% 133rd New leprosy case detection rate per 1 000 000 population 0 2024 — 124th Treatment success rate: HIV-positive TB cases 65 2023 up 12.1% 108th Prevalence of wasting, weight for height 3.5% 2002 up 6.1% 56th Peri-neonatal mortality by age of mother and parity, by NUTS 2 region 603 2023 down 23.4% 8th Fetal, peri- and neonatal mortality rates by NUTS 2 region of 2.29 2023 down 42.8% 25th Bladder cancer death rate 3.75 2022 up 5.3% 6th Cancer death rates by type who db 3.75 2022 up 5.3% 6th Earthquake deaths 2 1991 down 99.9% 30th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 66.0% 2025 — 137th International Health Regulations core capacity scores, SPAR version 50 2025 — 85th Prevalence of underweight, weight for age 3.5% 2002 down 30.0% 70th Health statistics - Regions (for 'Developer API') — Crude mortality 12.83 Per 1 000 inhabitants 2024 up 0.4% 8th Health status - Regions — Crude mortality rate 12.83 Per 1 000 inhabitants 2024 up 0.4% 8th Leprosy registered prevalence rate per 1 000 000 population 0 2024 down 100.0% 121st Leprosy - Number of new leprosy cases among children 0 2024 — 69th Leprosy - Number of cases registered for treatment 0 2024 down 100.0% 121st New leprosy child case detection rate (less than 15 years of age) per 0 2024 — 69th Children (0-14) living with HIV 200 2024 down 60.0% 77th Hospital discharges by diagnosis and NUTS 2 region, day cases, total 3.03 million 2021 up 154.5% 4th Hospital discharges by diagnosis and NUTS 2 region, day cases, total 1.73 million 2021 up 157.2% 4th Hospital discharges by diagnosis and NUTS 2 region, day cases, total 1.30 million 2021 up 151.0% 4th Hospital days of in-patients by NUTS 2 region - females - historical 9.66 million 2021 down 46.0% 7th Ipv1 number unvaccinated 38,948 2023 up 295.8% 62nd Children living with hiv 200 2024 down 60.0% 77th Hospital days of in-patients by NUTS 2 region - males - historical 9.86 million 2021 down 41.6% 7th Hospital days of in-patients by NUTS 2 region - total - historical 19.52 million 2021 down 43.9% 7th Hospital discharges by diagnosis and NUTS 2 region, in-patients 2.53 million 2021 down 45.5% 7th Hospital discharges by diagnosis, NUTS 2 region, in-patients and 1.35 million 2021 down 46.8% 7th Hospital discharges by diagnosis and NUTS 2 region, in-patients 1.18 million 2021 down 43.8% 7th Hospital discharges by diagnosis and NUTS 2 region, day cases, per 15,853 2021 up 184.7% 6th Hospital discharges by diagnosis and NUTS 2 region, day cases, per 17,655 2021 up 187.9% 6th Children (ages 0-14) newly infected with HIV 100 2024 unchanged 51st Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Age-standardized prevalence of current tobacco use among persons aged 29.7% 2024 down 9.5% 27th Hospital discharges by diagnosis and NUTS 2 region, day cases, per 13,954 2021 up 180.5% 7th Liver cancer death rate 6.41 2022 down 17.9% 15th Hospital discharges by diagnosis and NUTS 2 region, in-patients, per 13,212 2021 down 39.0% 17th Number of children newly infected with hiv 100 2024 unchanged 51st Share of children under fifteen years old with hiv 7.09 2024 down 67.1% 82nd Hospital discharges by diagnosis and NUTS 2 region, in-patients, per 13,740 2021 down 40.5% 19th Hospital discharges by diagnosis and NUTS 2 region, in-patients, per 12,656 2021 down 37.2% 17th Number of female leprosy new cases 0 2024 — 102nd National smoking ban: NUMBER OF PLACES SMOKE-FREE 8 2022 up 700.0% 1st Number of prevalent tuberculosis cases 20,000 2014 down 54.5% 59th Number of new G2D leprosy cases 0 2024 — 86th Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0 2024 — 86th Public health expenditure share gdp 4.76 2024 up 19.8% 43rd Proportion of total government spending on essential services, health 11.6% 2023 up 2.5% 53rd Pancreatic cancer death rate 6.8 2022 down 12.5% 39th Brain and nervous system cancer death rate 4.48 2022 down 18.5% 18th Inflation-adjusted prices for most sold brand of cigarettes: Prices 12.23 2022 up 11.2% 23rd Taxes as a % of price: total tax 69.1% 2022 down 5.7% 61st Taxes as a % of price: value added tax 16.0% 2022 down 17.6% 42nd Taxes as a % of price: ad valorem excise 14.0% 2022 down 30.0% 72nd Taxes as a % of price: specific excise 39.1% 2022 up 15.4% 46th Taxes as a % of price: import duties 0.0% 2022 — 37th Taxes as a % of price: other taxes 0.0% 2022 — 56th Inflation-adjusted prices for most sold brand of cigarettes: Price in 23.5 2022 up 25.3% 103rd ← Previous Page 16 of 20 Next →